Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Iradimed (IRMD) Revenue (2016 - 2025)

Iradimed (IRMD) has disclosed Revenue for 13 consecutive years, with $22.7 million as the latest value for Q4 2025.

  • Quarterly Revenue rose 17.03% to $22.7 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $83.8 million through Dec 2025, up 14.43% year-over-year, with the annual reading at $83.8 million for FY2025, 14.43% up from the prior year.
  • Revenue for Q4 2025 was $22.7 million at Iradimed, up from $21.2 million in the prior quarter.
  • The five-year high for Revenue was $22.7 million in Q4 2025, with the low at $9.2 million in Q1 2021.
  • Average Revenue over 5 years is $15.9 million, with a median of $16.3 million recorded in 2023.
  • Peak annual rise in Revenue hit 44.38% in 2021, while the deepest fall reached 6.3% in 2021.
  • Over 5 years, Revenue stood at $11.9 million in 2021, then grew by 25.19% to $14.9 million in 2022, then increased by 17.42% to $17.5 million in 2023, then increased by 11.1% to $19.4 million in 2024, then rose by 17.03% to $22.7 million in 2025.
  • According to Business Quant data, Revenue over the past three periods came in at $22.7 million, $21.2 million, and $20.4 million for Q4 2025, Q3 2025, and Q2 2025 respectively.